Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02867592
Title	Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	National Cancer Institute (NCI)
Indications	renal cell carcinoma central nervous system cancer medullary thyroid carcinoma sarcoma Advanced Solid Tumor adrenal cortex cancer renal Wilms' tumor Ewing sarcoma clear cell sarcoma hepatocellular carcinoma hepatoblastoma rhabdomyosarcoma alveolar soft part sarcoma
Therapies	Cabozantinib
Age Groups:	adult \| child
Covered Countries	USA